Cardiac Surgery and Heart Transplant Unit, Azienda Ospedaliera San Camillo Forlanini, Roma, Italy.
Cardiovascular Department, San Donato Hospital, Arezzo, Italy.
Am J Cardiol. 2024 Oct 1;228:1-9. doi: 10.1016/j.amjcard.2024.07.023. Epub 2024 Jul 23.
Coronary allograft vasculopathy (CAV) is a leading cause of morbidity and mortality after heart transplantation. CAV is often diagnosed in later stages or during routine screening in asymptomatic subjects. Myocardial work (MW), calculated using left ventricular global longitudinal strain (LV-GLS) and systemic blood pressure, may be associated with the presence of CAV and outperform conventional echocardiographic parameters. In this retrospective observational study, heart transplant recipients who underwent regular follow-up at our institution between May 2022 and September 2023 were enrolled. All included patients underwent speckle-tracking echocardiography, including MW indexes. CAV was classified according to invasive coronary angiography or computed tomography performed within 12 months of index echocardiography. We collected all available clinical and echocardiographic parameters and evaluated the potential association with CAV. CAV was detected in 29 of 93 patients (31%) (CAV+). Of the MW indexes, the mean global work efficiency (GWE) was 90 ± 6% and was significantly lower in CAV+ than CAV- subjects (86 ± 7% vs 91 ± 4%, p <0.001). GWE (OR 0.86, CI 0.77 to 0.94, p = 0.002), E/e' ratio (OR 1.27, CI 1.08 to 1.52, p = 0.006), and left ventricular ejection fraction (OR 0.90; CI 0.81 to 0.98, p = 0.017) were independently associated with the presence of CAV. GWE (GWE vs LV-GLS, delta area under the curve 0.154, p = 0.047) and the proposed model (GWE+E/e' vs LV-GLS, delta area under the curve 0.198, p = 0.004) were significantly superior in stratifying the incremental risk for CAV compared with LV-GLS. In conclusion, GWE was observed to be independently associated with the presence of CAV. MW could represent a novel noninvasive screening method for CAV in heart transplant recipients. Larger and prospective studies are needed to confirm this hypothesis.
冠状动脉移植血管病(CAV)是心脏移植后发病率和死亡率的主要原因。CAV 通常在无症状患者的后期或常规筛查中诊断出来。使用左心室整体纵向应变(LV-GLS)和全身血压计算的心肌做功(MW)可能与 CAV 的存在有关,并优于传统的超声心动图参数。在这项回顾性观察研究中,我们招募了 2022 年 5 月至 2023 年 9 月在我院接受定期随访的心脏移植受者。所有纳入的患者均接受斑点追踪超声心动图检查,包括 MW 指数。根据索引超声心动图后 12 个月内进行的有创冠状动脉造影或计算机断层扫描对 CAV 进行分类。我们收集了所有可用的临床和超声心动图参数,并评估了与 CAV 相关的潜在关联。在 93 名患者中有 29 名(31%)(CAV+)检测到 CAV。在 MW 指数中,平均整体工作效率(GWE)为 90±6%,在 CAV+患者中明显低于 CAV-患者(86±7%比 91±4%,p<0.001)。GWE(OR 0.86,CI 0.77 至 0.94,p=0.002)、E/e' 比值(OR 1.27,CI 1.08 至 1.52,p=0.006)和左心室射血分数(OR 0.90;CI 0.81 至 0.98,p=0.017)与 CAV 的存在独立相关。GWE(GWE 与 LV-GLS 相比,曲线下面积差异 0.154,p=0.047)和提出的模型(GWE+E/e' 与 LV-GLS 相比,曲线下面积差异 0.198,p=0.004)在分层 CAV 风险方面明显优于 LV-GLS。总之,观察到 GWE 与 CAV 的存在独立相关。MW 可能是心脏移植受者 CAV 的一种新的非侵入性筛查方法。需要更大的前瞻性研究来证实这一假设。